Inhalers that combine relieving breathlessness with preventing it seem to be the most effective option for reducing asthma ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies ...

The U.S. prescribing information for AIRSUPRA now includes results from the Phase IIIb BATURA trial, which demonstrated that ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...

The Trump administration is touting an old generic drug as a new treatment for autism despite limited evidence, sparking unease among doctors and scientists who say the medication needs to be ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

The effect of chronic breathlessness on the lives of patients and their loved ones is tremendous, regardless of the ...

Nerandomilast is both effective and well-tolerated, representing a "major step forward for the treatment of progressive pulmonary fibrosis (PPF)," with its effect on clinical outcomes sustained over ...